Cuban-Chinese Pharma Synergy: Joint R&D and Sales Initiative Targets USD 24.53 Billion in Sales
In a significant move to bolster its innovation pipeline, Guangzhou Pharmaceutical Holdings Ltd. has entered...
Guangzhou Pharma and BioCubaFarma Chart New Course with Joint Biologics R&D and Exchange Deal
Guangzhou Pharmaceutical Holdings Ltd., a prominent player in China’s pharmaceutical sector, has inked a strategic...
Hanx Biopharmaceuticals’ HX009 Receives NMPA Clinical Trial Approval for PD-1/CD47 Bispecific Antibody
China-based Hanx Biopharmaceuticals Co., Ltd has announced that its self-developed anti PD-1/CD47 bispecific antibody drug,...
LanssonPharm Secures Series A Funding to Accelerate CNS Drug Development
LanssonPharm, a company dedicated to the development of central nervous system (CNS) drugs, has announced...
China’s Ministry of Health Tightens Organ Transplant Regulations with Expert Conference
Shi Bingyi, a distinguished Member of the National Committee of the CPPCC (Chinese People’s Political...
China Launches Unprecedented Multi-Center Hypertension Study with Global Implications
On April 2nd, a landmark healthcare initiative, the “Hypertension Prevention and Treatment Research” project, commenced...
China Biopharma Posts 216% Revenue Increase, Eyes US$10 Million in 2007 with Vaccine Distribution and New Treatments
China Biopharma Corporation, trading on the OTC Bulletin Board under the symbol (CBPC.OB), announced a...
Shanghai to Launch China’s Largest ADR Database, Enhancing Pharmaceutical Oversight
Shanghai is advancing towards a significant milestone in pharmaceutical safety with plans to establish the...
China Unveils TCM Development Guidelines: A Strategic Defense of Traditional Medicine
In a strategic move to assert the value and historical significance of Traditional Chinese Medicine...
India Launches Anti-Dumping Campaign Against Chinese Vitamin B12 and Ceftriaxone Sodium Producers
In a strategic response to India’s Ministry of Commerce and Industry’s (MOFCOM) anti-dumping ruling against...
Novartis Sees 15% Global Sales Growth and Significant Investment in China for 2006
Novartis (NYSE: NVS), a multinational pharmaceutical giant, has reported a robust sales revenue of nearly...
Ruijin Hospital Researchers Uncover Five New Mutations in Rare 17OHD Endocrine Disorder
In a significant advancement in endocrine research, scientists within the Endocrine Department at Ruijin Hospital...
China’s SFDA Mandates Official Position Rotation to Boost Transparency
China’s State Food and Drug Administration (SFDA) is poised to embrace a new era of...
Guangdong’s ‘Sunlight Purchase’ System Sparks Drug Pricing War and Uncovers Pricing Anomalies
Since 2007, Guangdong province’s medical facilities have utilized an online procurement system known as “Sunlight...
Ruijin Hospital Unveils Five New Mutations in Rare Adrenal Hyperplasia Study
In a groundbreaking study, Ruijin Hospital’s Endocrine Department researchers identified five novel mutations in 17...
SFDA Embraces Transparency: Regular Press Briefings and Personnel Rotations Announced
China’s State Food and Drug Administration (SFDA) is gearing up for a transparency overhaul, with...
China’s Western Pharmaceutical Exports Soar 23% in 2006, Led by Antibiotics
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Shanghai Roche Pharmaceuticals Launches Erlotinib for Advanced Non-Small Cell Lung Cancer in China
Shanghai Roche Pharmaceuticals Ltd. made headlines in March with the launch of its lung cancer...